Access Secure Information About Our Products
Sign in to access authorized secure information. Learn more about secure access rights.
The standing committees of the Board are the audit committee, the human resources and compensation committee, and the nominating, governance and sustainability committee.
All members of the committees are independent directors, as defined in the applicable Nasdaq listing standards for purposes of the respective committee membership, applicable Securities and Exchange Commission (SEC) rules and the Dutch Corporate Governance Code (DCGC).
In addition, the Board has determined that all audit committee members are able to read and understand fundamental financial statements in accordance with Nasdaq listing standards and that all current members of the audit committee meet the SEC’s definition of “audit committee financial expert” as that term is defined in Item 407(d) of Regulation S-K.
Sign in to access authorized secure information. Learn more about secure access rights.
Important: After email verification refresh this page.
Highly secure information about this product portfolio is available, request access rights. Learn more about secure access rights.
Note: Your application will be reviewed individually by NXP. A non-disclosure agreement will help expedite this process.
Your request to gain secure access rights has been declined. If you think this has been declined in error, request access again.
Access More. Additional secure (restricted) information is available for this product portfolio. Request additional access.
We are currently processing your secure access rights request. Once processed, a notification will be sent to ${emailId}.
Some files related to your secure access rights are temporary unavailable due to a system error. Please check back.
Your access to some secure information has been disabled while we process the updates you made to your NXP Account > Profile. We'll send you an email when the verification process is completed.
There is no information to display.
500 characters remaining.
*Describe the justification for your access request for the approver.